Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02989142
Other study ID # T005116N
Secondary ID
Status Recruiting
Phase N/A
First received August 29, 2016
Last updated June 9, 2017
Start date April 1, 2017
Est. completion date September 2020

Study information

Verified date June 2017
Source Katholieke Universiteit Leuven
Contact Annick Bogaerts, PhD
Phone ++3216342810
Email annick.bogaerts@ucll.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The project focuses on prevention of major pregnancy and birth related complications : pregnancy-induced hypertension (PIH), gestational diabetes mellitus (GDM), caesarean section (CS), and large-for-gestational-age (LGA), i.e. the birth weight of the baby exceeds the 90% percentile of birth weights for the specific pregnancy duration.

The investigators focus on the pre-conception period, i.e. the pre-conception period of the 2nd pregnancy in women with an excessive weight gain during their 1st pregnancy, aiming to decrease the complications rate in their 2nd pregnancy.

Women with an excessive gestational weight gain have obtained the extra weight during a rather short period of time, e.g. 20 kilos in the last 4 or 5 months of their pregnancy. This characteristic distinguishes the target group from the general population with overweight/obesity, in whom the extra weight was acquired during many years and independent from a pregnancy, making a behaviour change more complex.

The coaching intervention combines face-to-face counselling with the use of a mobile App connected to medical devices (scale and pedometer). The app monitors important indicators (weight, eating behaviour, physical activity, mental wellbeing), provides coaching through established behavioral change techniques, and is specifically tailored for women with excessive weight gain during the previous pregnancy.

The goal is to decrease the rate of pregnancy and birth-related adverse outcomes in the next pregnancy by a healthy life style, starting shortly after their 1st delivery and sustained during the next pregnancy.


Description:

The aim is to decrease the prevalence of pregnancy and birth-related complications (pregnancy-induced hypertension (PIH), gestational diabetes mellitus (GDM), caesarean section (CS), and large-for-gestational-age babies (LGA)). These complications occur in 26% of pregnancies with normal start BMI and adequate weight gain, in 34% in normal start BMI but excessive gestational weight gain and in up to 66% in obese class III (BMI≥40kg/m²) combined with excessive gestational weight gain. Moreover, as the prevalence of maternal obesity continues to rise, increasing numbers of children are exposed to an 'obesogenic intrauterine environment'. Obesity in pregnancy has therefore the potential to result in an 'intergenerational cycle' of obesity through in utero programming.

The investigators focus on women with excessive weight gain during their 1st pregnancy as currently, half of them do not return to their pre-pregnancy weight before the next pregnancy. This results in a complication rate as high as 42% (PIH, GDM, CS, LGA). The investigators target a healthy BMI at start of pregnancy by intervening during the pre-conception period- and an adequate weight gain during pregnancy by intervening during pregnancy in these women. The intervention will be evaluated in a randomized controlled trial including 1,100 women.

The proposed intervention combines face-to-face coaching with the use of a mobile App (so-called 'inter-act' app) connected to medical devices (scale and pedometer). The app monitors women's weight, eating behaviour, physical activity, mental wellbeing, and provides continuously coaching through positive behavioral change techniques. The 'inter-act' App covers after the 1st delivery breast-feeding support, while during pregnancy, the gestational weight gain guidelines of the Institute of Medicine (IOM) are included.

Drop out of less motivated women is avoided as the time points of the four pre-conception coaching sessions coincide with the existing postnatal follow-up visits for neonates (Governmental vaccination scheme through the organisation " Kind & Gezin"), and the three pregnancy coaching sessions coincide with the three routine ultrasound scans during normal pregnancy (KCE Guidelines).

Each year, there are 8,900 singleton pregnancies in Flanders in whom the mother had excessive gestational weight gain in the prior pregnancy. The current rate of at least one of the four major pregnancy and birth-related complications (PIH, GDM, CS, LGA) in the 8,900 pregnancies is 42%. If the complications rate reduces with 1/4, this involves more than 900 pregnancies, and reduces costs related to caesarean sections, gestational diabetes, obesity in mother & child.


Recruitment information / eligibility

Status Recruiting
Enrollment 1100
Est. completion date September 2020
Est. primary completion date March 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Excessive weight gain during their previous pregnancy (above the IOM recommendations)

- Child wish for having a next pregnancy

- Women aged 18 years or more

- Sufficient fluent in Dutch language

- Able to give written informed consent

- Able to use a smartphone. If the women do not have a smartphone because of socio-economic reasons, a smartphone is at her disposal for the whole duration of the intervention, in order to be able to use Apps connected with a Bluetooth pedometer and balance scale.

Exclusion Criteria:

- Requirement for (complex) diets

- History of or a plan for bariatric surgery

- Underlying or chronic disorders (e.g. diabetes, thyroid disease, renal diseases)

- Significant psychiatric disorder

- Previous still birth

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
INTER-ACT
Pre-conception coaching sessions: We encourage less motivated women to participate to the trial by collaborating with Kind & Gezin from the very beginning, as most timepoints of the counselling sessions coincide with the time points of the Kind&Gezin vaccine scheme (postpartum week 6, week 8, week 12, 6 months). We will organize the coaching in a "mother and baby friendly" community-based setting or in the hospitals, as preferred by the mothers. Pregnancy coaching sessions: take place in hospital, at the time of the three planned ultrasound scans. By consequence, the applied methodology can be applied as such at the moment of global utilisation in Flanders.

Locations

Country Name City State
Belgium UZA Antwerpen
Belgium Ziekenhuizen GasthuisZusters Antwerpen (GZA) Antwerpen
Belgium Ziekenhuis Oost-Limburg (ZOL) Genk
Belgium Jessa ziekenhuis Hasselt
Belgium Sint-Franciskusziekenhuis Heusden
Belgium UZ Leuven Leuven

Sponsors (3)

Lead Sponsor Collaborator
Katholieke Universiteit Leuven UC Leuven-Limburg, Universiteit Antwerpen

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary prevalence of participants with at least one of the following four complications: pregnancy-induced hypertension, gestational diabetes mellitus, caesarean section, large-for-gestational age baby The existence of pregnancy-induced hypertension and gestational diabetes mellitus are assessed during pregnancy. Whether the 2nd pregnancy results in a caesarean section and large-for-gestational-age baby will be known at the time of delivery 2nd pregnancy. Therefore, the primary outcome of prevalence of participants with pregnancy and birth-related complications is assessed at the time of delivery 2nd pregnancy. at the time of delivery 2nd pregnancy (max pregnancy duration 44 weeks)
Secondary Drop out Drop-out rate and reason for drop-out at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Rate of women who returned to their pre-pregnancy weight at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Distribution underweight, normal weight, overweight, obese BMI at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Body composition Body composition measured by bio-electrical impedance analysis to estimate fat mass, fat free mass and muscle mass. at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Skin fold measurements Skin fold measurements or determining body fat composition by use of a skinfold calliper. at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Breast feeding behaviour Breast feeding (BF) habits are assessed by a structured questionnaire on breastfeeding practice. The questionnaire consists of eleven questions in Dutch, which investigates intention to BF, initiation to BF, exclusive BF, combination of bottle-feeding and BF and motives to cease BF. at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Food intake food intake is measured by a Food Frequency Questionnaire: frequency of food intake (per day, per week or per month) and portion size (in gram or millilitre). at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Physical activity Physical activity is measured using International Physical Activity Questionnaire (IPAQ), long version. at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Life style behaviour Life style behaviour: whether the mother is following a diet, smoking, sleep duration and quality of sleep, alcohol use (questionnaire). at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Anxiety Anxiety symptoms are measured with the Trait Anxiety Inventory (TAI). at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary Depression Levels of depression are measured with the reliable and valid 10-item Edinburgh Postnatal Depression Scale (PDS). at 6 months, at 12 months, at 18 months .... till delivery 2nd pregnancy
Secondary rate of patients with excessive gestational weight gain during their 2nd pregnancy. at the time of delivery 2nd pregnancy (max pregnancy duration 44 weeks)
Secondary Rate of preterm/term pregnancies at the time of delivery 2nd pregnancy (max pregnancy duration 44 weeks)
Secondary Cost-effectiveness of the intervention Costs related to these complications:
caesarean section costs 4,013€ compared to 2,909€ for a vaginal delivery, resulting in a 4,013-2,909= 1,104€ additional cost per caesarean section (Onafhankelijke Ziekenfondsen, 2012).
Gestational diabetes has an additional cost 820 € (Danyliv et al., IADPSG 2014, Gestational Diabetes and health care cost).
There is also the impact of gestational diabetes on the baby. Intrauterine exposure through gestational diabetes predisposes the off-spring to diabetes: yearly cost for diabetes around 5,800€ (American Diabetes Association).
Obesity: yearly additional direct medical cost for obesity approximately 3000 € per person due to increased contacts with health care providers and hospitalisation costs (De Jonghe E and Annemans L, 2009).
The costs of the coaching sessions are based on the official nomenclature of midwives (RIZIV - Rijksinstituut voor ziekte- en invaliditeitsverzekering, Belgian institute)
at the time of delivery 2nd pregnancy (max pregnancy duration 44 weeks)
Secondary Number of women who gave at least 6 months breast feeding at 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2